Marriott International
Stocks
Thermo Fisher Scientific Inc
Stocks
Marriott International vs Thermo Fisher Scientific Inc: A Data-Driven Performance Comparison
Last updated: June 7, 2026
Summary
Marriott International and Thermo Fisher Scientific Inc operate in vastly different sectors, but their performance indicators reveal distinct strengths. While Marriott excels with a higher revenue relative to its sector, Thermo Fisher outperforms in profitability and valuation metrics, reflecting stronger financial health and growth prospects.
Key Differences at a Glance
| Aspect | Marriott International | Thermo Fisher Scientific Inc | Winner |
|---|---|---|---|
| Market Capitalization | Approximately $103.5 billion | Approximately $175.7 billion | Thermo Fisher Scientific Inc |
| Earnings Per Share (EPS) | 9.56 | 18.2 | Thermo Fisher Scientific Inc |
| Price-to-Earnings (P/E) Ratio | 41.06 | 26.00 | Thermo Fisher Scientific Inc |
| Profit Margin | 35.97% | 15.15% | Marriott International |
| Beta (Market Volatility) | 1.105 | 0.874 | Thermo Fisher Scientific Inc |
Market Capitalization: Thermo Fisher has a significantly higher market cap by about $72.2 billion, indicating greater investor confidence and valuation driven by its leadership in the healthcare diagnostics and research sector.
Earnings Per Share (EPS): Thermo Fisher's EPS of 18.2 nearly doubles Marriott's 9.56, signalling superior profitability per share, which is crucial for assessing long-term performance potential.
Price-to-Earnings (P/E) Ratio: Thermo Fisher’s lower P/E ratio of 25.98 suggests it is more attractively valued relative to its earnings, whereas Marriott’s higher ratio of 41.06 indicates a premium placed on future growth expectations in the hospitality sector.
Profit Margin: Marriott’s profit margin of 35.97% surpasses Thermo Fisher’s 15.15%, reflecting higher efficiency in converting revenue into profit, which is typical for service-oriented businesses like hospitality.
Beta (Market Volatility): Thermo Fisher’s lower beta suggests it is less volatile and potentially a safer investment amidst market fluctuations compared to Marriott’s higher beta of 1.105.
Detailed Analysis
Marriott International demonstrates impressive revenue generation with approximately $7.18 billion, positioning it as a dominant player in the global lodging industry. Its revenue, combined with a high profit margin of 35.97%, underscores its operational efficiency, especially considering its 414,000 employees. The company's PE ratio of 41.06 indicates that investors are willing to pay a premium for future growth, which is typical in the cyclical consumer discretionary sector. Meanwhile, its forward PE of roughly 30 suggests expectations of earnings growth, but still at a premium relative to earnings.
Thermo Fisher Scientific, with revenue exceeding $45 billion, dwarfs Marriott in absolute sales figures, reflecting its leadership in diagnostics and research within the healthcare sector. Its EPS of 18.2 and profit margin of 15.15% highlight robust profitability, especially given its extensive product portfolio and global reach. The company's lower P/E ratio of 25.98 signals a more attractive valuation, possibly due to its diversified product lines and steady demand in healthcare.
In stability and risk metrics, Thermo Fisher's beta of 0.874 indicates less market volatility compared to Marriott’s 1.105. This lower beta, combined with its higher market cap and consistent revenue streams, makes it a potentially safer investment in turbulent markets. Conversely, Marriott’s higher profit margin and revenue per employee point to operational efficiencies in its industry, but its higher valuation multiple and market volatility suggest it is more growth-oriented and sensitive to economic cycles.
Overall, while Marriott excels in profit margins and operational efficiency typical of service industries, Thermo Fisher outperforms in profitability, valuation, and stability metrics. These contrasting strengths highlight the different performance-focused dynamics within their respective sectors, making each suitable for different investor strategies depending on risk appetite and sector preference.
Verdict
Thermo Fisher Scientific Inc emerges as the stronger performer in terms of profitability, valuation, and market stability, making it a better choice for investors seeking growth and lower risk. Marriott International, while highly efficient and profitable in its hospitality niche, trades at a premium valuation and exhibits higher volatility. Therefore, for investors prioritizing stability and high earnings potential, Thermo Fisher presents a more compelling performance-driven option.
Who Should Choose What
Choose Marriott International if...
Best for investors looking for exposure to the global hospitality sector with strong profit margins and operational efficiency, especially in cyclical markets where revenue stability is valued.
Choose Thermo Fisher Scientific Inc if...
Best for investors seeking a leading healthcare stock with high EPS, attractive valuation ratios, and lower market volatility, ideal for growth-oriented or risk-averse portfolios.
Learn More
Related Comparisons
Bunge Limited vs Thermo Fisher Scientific Inc: A Price-Focused Comparison for Investors
Equinix, Inc. vs Thermo Fisher Scientific Inc: Practical Daily-Use Stock Comparison
Merck & Company, Inc. vs Thermo Fisher Scientific Inc: Practical Daily-Use Stock Comparison
Marriott International vs HP Inc.: A Data-Driven Comparison for Investors and Business Strategists
Qualys, Inc. vs Thermo Fisher Scientific Inc: Long-Term Investment Analysis for Tech vs Healthcare Stocks